CN101843831B - Chinese medicament for treating diabetic cardiopathy - Google Patents
Chinese medicament for treating diabetic cardiopathy Download PDFInfo
- Publication number
- CN101843831B CN101843831B CN2009102354936A CN200910235493A CN101843831B CN 101843831 B CN101843831 B CN 101843831B CN 2009102354936 A CN2009102354936 A CN 2009102354936A CN 200910235493 A CN200910235493 A CN 200910235493A CN 101843831 B CN101843831 B CN 101843831B
- Authority
- CN
- China
- Prior art keywords
- chinese
- radix
- chinese medicine
- fine powder
- chinese medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 27
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 15
- 241000222336 Ganoderma Species 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 3
- 239000000843 powder Substances 0.000 claims description 17
- 239000002775 capsule Substances 0.000 claims description 16
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 11
- 241000180649 Panax notoginseng Species 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 3
- 238000003809 water extraction Methods 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 13
- 239000008280 blood Substances 0.000 abstract description 10
- 210000004369 blood Anatomy 0.000 abstract description 10
- 208000002193 Pain Diseases 0.000 abstract description 6
- 201000010099 disease Diseases 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 238000005728 strengthening Methods 0.000 abstract description 4
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000729196 Lycopus lucidus Species 0.000 abstract 1
- 240000002948 Ophiopogon intermedius Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 230000007721 medicinal effect Effects 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 description 6
- 206010040007 Sense of oppression Diseases 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 206010049119 Emotional distress Diseases 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 241000207961 Sesamum Species 0.000 description 3
- 235000003434 Sesamum indicum Nutrition 0.000 description 3
- 230000000747 cardiac effect Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000009429 distress Effects 0.000 description 3
- AXONCVPTTFHNOI-UHFFFAOYSA-N kairine Chemical compound C1=CC(O)=C2N(C)CCCC2=C1 AXONCVPTTFHNOI-UHFFFAOYSA-N 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- SJSOFNCYXJUNBT-UHFFFAOYSA-N 3,4,5-trimethoxybenzoic acid Chemical compound COC1=CC(C(O)=O)=CC(OC)=C1OC SJSOFNCYXJUNBT-UHFFFAOYSA-N 0.000 description 2
- 208000001871 Tachycardia Diseases 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000006794 tachycardia Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010059245 Angiopathy Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229940127003 anti-diabetic drug Drugs 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000088 lip Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to a Chinese medicament for treating diabetic cardiopathy, and belongs to the field of Chinese medicaments for treating cardio-cerebral-vascular system diseases. The invention aims to provide the Chinese medicament with good effect and quick response. The Chinese medicament is prepared from the following raw materials: hiraute shiny bugleweed herb, Chinese angelica, dwarf lilyturf tuber, root of rehmannia, radix pseudo-ginseng, lucid ganoderma, Chinese magnoliavine fruit and the like. The Chinese medicament has the effects of strengthening body resistance and banking up root, tonifying qi and nourishing blood, nourishing Yin and clearing heat, and activating blood, dissolving stasis and relieving pain, and has the advantages of obvious effect, exact medicinal effect and quick response.
Description
Technical field
The invention belongs to the field of Chinese medicines of treatment diseases of cardiovascular and cerebrovascular systems.
Background technology
Diabetic cardiopathy is due to diabetictrunk angiopathy and the neuropathy, is one of diabetes most common complication, also is the main cause of death of diabetics.According to statistics, diabetics 70% is died from diabetic cardiopathy.The present deficiency that is intended to treat two aspects of existence, diabetic cardiopathy aspect: the one, effect is obvious inadequately, the 2nd, it is slower to take effect, so that many diabetic cardiopathy patients are owing to can not get the treatment of active drug, stand the torment of feeling of oppression and pain in the chest, palpitation and uneasiness for a long time, face the danger of myocardial infarction, patient and family members thereof are dissatisfied to this.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of diabetic cardiopathy, it can solve, and this type of Chinese medicine effect was obvious inadequately in the past, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
A kind of Chinese medicine for the treatment of diabetic cardiopathy adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Herba Lycopi 3-20 part Radix Angelicae Sinensis 4-30 part 4-30 Radix Ophiopogonis part
Radix Rehmanniae 4-30 part Radix Notoginseng 3-20 part Ganoderma 2-12 part
Fructus Schisandrae Chinensis 3-20 part
The Chinese medicine of this treatment diabetic cardiopathy is made by following method:
(1) by above-mentioned weight ratio, Herba Lycopi, Radix Angelicae Sinensis, Radix Ophiopogonis, the Radix Rehmanniae, Fructus Schisandrae Chinensis are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Ganoderma benefiting QI and nourishing blood in the side, tranquilizing by nourishing the heart, the body resistance strengthening and constitution consolidating, enhancing human body immunity power; Radix Rehmanniae is sweet cold, is longer than nourishing YIN and clearing away heat, pursues arthralgia due to stagnation of blood and blood stasis dispelling; Radix Ophiopogonis sweet cold YIN nourishing and the production of body fluid promoting; The trimethyl gallic acid temperature, supplementing QI for promoting the production of body fluid, kidney calming upward is a principal agent; Be aided with Radix Angelicae Sinensis, Radix Notoginseng nourshing blood and promoting blood circulation, blood-activating analgetic; Herba Lycopi's blood circulation promoting and blood stasis dispelling, line water detumescence.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and nourishing YIN and clearing away heat, the merit of promoting blood circulation, removing blood stasis and relieving pain, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Herba Lycopi's 60 gram Radix Angelicae Sinensis 80 gram grams Radix Ophiopogonis 80
The Radix Rehmanniae 80 gram Radix Notoginseng 60 kairine sesames 40 grams
Fructus Schisandrae Chinensis 60 grams
Weight in accordance with regulations, with conventional water extraction process Herba Lycopi, Radix Angelicae Sinensis, Radix Ophiopogonis, the Radix Rehmanniae, Fructus Schisandrae Chinensis are extracted, make extractum fine powder 108 grams, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 742 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Herba Lycopi's 100 gram Radix Angelicae Sinensis 160 gram grams Radix Ophiopogonis 160
The Radix Rehmanniae 160 gram Radix Notoginseng 100 kairine sesames 60 grams
Fructus Schisandrae Chinensis 100 grams
By above-mentioned same method, make 1300 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
Herba Lycopi's 200 gram Radix Angelicae Sinensis 300 gram grams Radix Ophiopogonis 300
The Radix Rehmanniae 300 gram Radix Notoginseng 200 kairine sesames 120 grams
Radix Rehmanniae 200 grams
By above-mentioned same method, make 2535 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
8 parts of 6 parts of Radix Angelicae Sinensis of Herba Lycopi 8 parts of Radix Ophiopogonis
4 parts of 6 portions of Ganodermas of 8 portions of Radix Notoginseng of the Radix Rehmanniae
6 parts of Fructus Schisandrae Chinensis
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
22 parts of 15 parts of Radix Angelicae Sinensis of Herba Lycopi 22 parts of Radix Ophiopogonis
10 parts of 15 portions of Ganodermas of 22 portions of Radix Notoginseng of the Radix Rehmanniae
15 parts of Fructus Schisandrae Chinensis
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science diabetic cardiopathy, through 8 routine clinical observations.Selecting the tcm diagnosis diabetic cardiopathy is standard: the diabetics soreness of the waist and knees, and health is weak; Feeling of oppression and pain in the chest, palpitation and uneasiness; Cardiac distresses such as tachycardia are often arranged.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 5 examples, women's 3 examples do not have other serious disease, and the age is 48 years old-78 years old, 59.7 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, and on one's body energetically, cardiac distresses such as feeling of oppression and pain in the chest, palpitation and uneasiness, tachycardia are obviously alleviated, and the visible blood supply of cardiac muscle of electrocardiogram improves.
2, effective: body constitution strengthens, and cardiac distresses such as feeling of oppression and pain in the chest are alleviated to some extent.
3, invalid: the disease no change.
During clinical experiment, except that the antidiabetic drug that diabetics is necessary is taken (medicine is constant, amount is constant) as usual, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 3 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 30 days, take 3 months after, symptom is obviously improved.8 philtrums of clinical experiment, produce effects 4 people, effective 3 people, invalid 1 people, total effective rate 87.5%.
Claims (1)
1. a Chinese medicine for the treatment of diabetic cardiopathy adopts the raw material of Chinese medicine preparation, it is characterized in that it is to make with the component of following weight ratio:
Herba Lycopi 3-20 part Radix Angelicae Sinensis 4-30 part 4-30 Radix Ophiopogonis part
Radix Rehmanniae 4-30 part Radix Notoginseng 3-20 part Ganoderma 2-12 part
Fructus Schisandrae Chinensis 3-20 part
The Chinese medicine of this treatment diabetic cardiopathy is made by following method:
(1) by above-mentioned weight ratio, Herba Lycopi, Radix Angelicae Sinensis, Radix Ophiopogonis, the Radix Rehmanniae, Fructus Schisandrae Chinensis are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; Make Chinese medicine granules, powder, capsule, watered pill, tablet.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102354936A CN101843831B (en) | 2009-10-16 | 2009-10-16 | Chinese medicament for treating diabetic cardiopathy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102354936A CN101843831B (en) | 2009-10-16 | 2009-10-16 | Chinese medicament for treating diabetic cardiopathy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101843831A CN101843831A (en) | 2010-09-29 |
| CN101843831B true CN101843831B (en) | 2011-06-29 |
Family
ID=42768769
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009102354936A Expired - Fee Related CN101843831B (en) | 2009-10-16 | 2009-10-16 | Chinese medicament for treating diabetic cardiopathy |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101843831B (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101112514A (en) * | 2007-08-29 | 2008-01-30 | 北京艺信堂医药研究所 | Chinese medicine preparation for treating diabetic cardiac disease |
| CN101129762A (en) * | 2007-08-29 | 2008-02-27 | 北京艺信堂医药研究所 | Traditional Chinese medicine preparation for treating diabetes cardiac disease |
-
2009
- 2009-10-16 CN CN2009102354936A patent/CN101843831B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101112514A (en) * | 2007-08-29 | 2008-01-30 | 北京艺信堂医药研究所 | Chinese medicine preparation for treating diabetic cardiac disease |
| CN101129762A (en) * | 2007-08-29 | 2008-02-27 | 北京艺信堂医药研究所 | Traditional Chinese medicine preparation for treating diabetes cardiac disease |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101843831A (en) | 2010-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101843712B (en) | Chinese medicament for treating angina | |
| CN101843709B (en) | Chinese medicament for treating abnormal menstruation | |
| CN101843878B (en) | Chinese medicament for treating diabetic cardiopathy | |
| CN101843755A (en) | Chinese medicament for treating diabetic cardiopathy | |
| CN101843807A (en) | Chinese medicament for treating diabetic cardiopathy | |
| CN101843831B (en) | Chinese medicament for treating diabetic cardiopathy | |
| CN101843717B (en) | Chinese medicament for treating coronary disease | |
| CN101843707B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101850055B (en) | Chinese medicament for treating coronary heart diseases | |
| CN101843644B (en) | Chinese medicament for treating tachycardia | |
| CN101850054B (en) | Chinese medicament for treating diabetic heart diseases | |
| CN101843705B (en) | Chinese medicament for treating lupus erythematosus | |
| CN101843753B (en) | Chinese medicament for treating angina | |
| CN101843693A (en) | Chinese medicament for treating diabetic nephropathy | |
| CN101843832B (en) | Chinese medicament for treating coronary disease | |
| CN101843835B (en) | Chinese medicament for treating coronary diseases | |
| CN101843817B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101849985B (en) | Chinese medicament for treating tachycardia | |
| CN101843793B (en) | Chinese medicament for treating tachycardia | |
| CN101843758B (en) | Chinese medicament for treating coronary disease | |
| CN101843720B (en) | Chinese medicament for treating angina | |
| CN101843805A (en) | Chinese medicament for treating diabetic cardiopathy | |
| CN101843796A (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101843797A (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101843700A (en) | Chinese medicament for treating coronary disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: LIU XINZHUANG Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20150722 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20150722 Address after: 100040 Beijing city Shijingshan District double Jinyuan District 16 Building 2 unit 1102 Patentee after: Liu Xinzhuang Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd. |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20160322 Address after: 030006 Shanxi province Taiyuan city dock Xiaodian District in South Lihua court 13 Building 2 Room 302 Patentee after: Tian Runsheng Address before: 100040 Beijing city Shijingshan District double Jinyuan District 16 Building 2 unit 1102 Patentee before: Liu Xinzhuang |
|
| DD01 | Delivery of document by public notice |
Addressee: Tian Runsheng Document name: Notification of Passing Examination on Formalities |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110629 Termination date: 20171016 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |